İçeriğe geç
akaturk Akademik ölçüm

Akademisyen

BİRSEN TOZKOPARAN KÖPRÜCÜ

PROFESÖR

HACETTEPE ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Farmasotik Kimya

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 46
  • Proje 0
  • Kitap 8
  • Bildiri 13
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 12 Q2 12 Q3 6 Q4 2
WoS (JCR) Q1 4 Q2 12 Q3 14 Q4 8
TR Index 0 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 3
Ort. yüzdelik 63.2%
Üst %1 payı 0.0%
Üst %10 payı 12.5%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 46 yayın

Makale listesi

  1. 2025 Synthesis and biological evaluation of novel naproxen–phenacetin triazole hybrids as promising anti-inflammatory agents with enhanced gastrointestinal tolerability Bioorganic Chemistry DOI 10.1016/j.bioorg.2025.109000 YÖKSİS SJR Q1 JCR Q1 OpenAlex 11.3%
  2. 2025 Some novel 5-benzylidenethiazolo[3,2-b]-1,2,4-triazole-6(5H)-one derivatives in the battle against cancer: Design, synthesis and their biological activities Journal of Molecular Structure DOI 10.1016/j.molstruc.2024.141169 YÖKSİS SJR Q2 JCR Q2 OpenAlex 54.5%
  3. 2024 Synthesis, characterization, and MAO inhibitory activities of three new drug-like N-acylhydrazone derivatives Journal of Molecular Structure DOI 10.1016/j.molstruc.2024.139228 YÖKSİS SJR Q2 JCR Q2 OpenAlex 78.9%
  4. 2022 Design, Synthesis and Biological Evaluation of Novel Triazolothiadiazoles Derived from NSAIDs as Anticancer Agents Anti-Cancer Agents in Medicinal Chemistry DOI 10.2174/1871520621666210623093550 YÖKSİS SJR Q3 JCR Q3 OpenAlex 51.8%
  5. 2022 A new triazolothiadiazine derivative inhibits stemness and induces cell death in HCC by oxidative stress dependent JNK pathway activation Scientific Reports (Sci Rep) DOI 10.1038/s41598-022-17444-0 YÖKSİS SJR Q1 JCR Q2 OpenAlex 66.4%
  6. 2020 Synthesis, characterization, and in vivo pharmacological evaluation of novel mannich bases derived from 1,2,4-triazole containing a naproxen moiety Bioorganic Chemistry DOI 10.1016/j.bioorg.2020.103892 YÖKSİS SJR Q2 JCR Q1 OpenAlex 88.0%
  7. 2019 Synthesis and structural characterisation of 3-[1-[4-(2-methylpropyl) phenyl]ethyl]-6-(4-fluorophenyl)-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole Powder Diffraction DOI 10.1017/S0885715619000654 YÖKSİS SJR Q3 JCR Q4 OpenAlex 38.5%
  8. 2017 Design and Synthesis of 1,2,4-Triazolo[3,2-b\n]-1,3,5-thiadiazine Derivatives as a Novel Template for Analgesic/Anti-Inflammatory Activity Archiv der Pharmazie DOI 10.1002/ardp.201700052 YÖKSİS SJR Q2 JCR Q2 OpenAlex 64.1%
  9. 2017 Structure elucidation of 3-[1-(6-methoxy-2-naphtyl)ethyl]-6-(2,4-dichlorophenyl)-7H-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazine, C23H18Cl2N4OSfrom synchrotron X-ray powder diffraction POWDER DIFFRACTION YÖKSİS SJR Q3 JCR Q4
  10. 2016 Novel triazolothiadiazines act as potent anticancer agents in liver cancer cells through Akt and ASK 1 proteins Bioorganic and Medicinal Chemistry YÖKSİS
  11. 2015 Novel thiazolo 3 2 b 1 2 4 triazoles derived from naproxen with analgesic anti inflammatory properties Synthesis biological evaluation and molecular modeling studies Bioorganic & Medicinal Chemistry DOI 10.1016/j.bmc.2015.03.049 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 96.9%
  12. 2012 Thiazolo 3 2 b 1 2 4 triazole 5 6H one substituted with ibuprofen Novel non steroidal anti inflammatory agents with favorable gastrointestinal tolerance European Journal of Medicinal Chemistry DOI 10.1016/j.ejmech.2012.07.009 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 91.8%
  13. 2012 Novel 1 2 4 Triazolo 3 4 b 1 3 4 thiadiazole Derivatives as Dual Analgesic Anti inflammatory and Antimicrobial Agents Letters in Drug Design & Discovery DOI 10.2174/157018012799079626 YÖKSİS SJR Q2 JCR Q4 OpenAlex 52.9%
  14. 2012 Design and synthesis of some thiazolotriazolyl esters as anti inflammatory and analgesic agents Medicinal Chemistry Research DOI 10.1007/s00044-010-9508-x YÖKSİS SJR Q1 JCR Q3 OpenAlex 60.1%
  15. 2010 A joint theoretical and experimental structural study of two novel 1 2 4 triazolo 3 4 b 1 3 4 thiadiazine derivatives Structural Chemistry DOI 10.1007/s11224-010-9613-y YÖKSİS SJR Q3 JCR Q2 OpenAlex 65.4%
  16. 2009 Synthesis of 3 6 disubstituted 7H 1 2 4 triazolo 3 4 b 1 3 4 thiadiazines as novel analgesic anti inflammatory compounds European Journal of Medicinal Chemistry DOI 10.1016/j.ejmech.2009.06.026 YÖKSİS SJR Q1 JCR Q1 OpenAlex 80.0%
  17. 2009 Novel 3 6 disubstituted 7H 1 2 4 triazolo 3 4 b 1 3 4 thiadiazines synthesis characterization and evaluation of analgesic anti inflammatory antioxidant activities Archiv der Pharmazie DOI 10.1002/ardp.200800188 YÖKSİS SJR Q1 JCR Q2 OpenAlex 73.5%
  18. 2009 Investigation of antioxidant properties of some 6 aminobenzyl thiazolo 3 2 b 1 2 4 triazole 5 ol compounds Journal of Enzyme Inhibition and Medicinal Chemistry DOI 10.1080/14756360802519798 YÖKSİS SJR Q2 JCR Q3 OpenAlex 75.4%
  19. 2007 Design and synthesis of some new thiazolo 3 2 b 1 2 4 triazole 5 6H ones substituted with flurbiprofen as anti inflammatory and analgesic agents Arzneimittel-Forschung/Drug Research YÖKSİS JCR Q3
  20. 2007 Preparation of 5 aryl 3 alkylthio l 2 4 triazoles and corresponding sulfones with antiinflammatory analgesic activity Bioorganic & Medicinal Chemistry DOI 10.1016/j.bmc.2006.11.029 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 90.5%

Akademisyenlere dön